What are the molecular differences between mitochondrial DNA (mtDNA)-deficient and mtDNA-normal oocytes and how does mitochondrial supplementation alter these?
Introduction
Mitochondria are organelles that possess between 2 and 10 copies of mitochondrial DNA (mtDNA) (Satoh and Kuroiwa, 1991) . In mammals, mtDNA is a circular, double-stranded genome of~16.6 kb in size that encodes 13 subunits of the electron transfer chain (ETC), which generates the vast majority of cellular ATP through oxidative phosphorylation (OXPHOS) (Shadel and Clayton, 1997) . It also encodes 2 ribosomal RNAs, and 22 transfer RNAs, and consists of one major non-coding region, the D-loop, which contains the control region and two hypervariable regions (Shadel and Clayton, 1997) .
Transcription and replication of mtDNA are regulated by nuclearencoded factors that interact with the control region (Shadel and Clayton, 1997) . One key factor is the catalytic subunit of the mtDNAspecific replication factor, DNA Polymerase Gamma (POLG), which is DNA methylated in a cell-specific manner and correlates with a specialised cell's distinct numbers of mtDNA copy (Kelly et al., 2012; Lee et al., 2015) . This enables the cell to generate sufficient ATP through OXPHOS to undertake its specialised functions (St John et al., 2010) . POLG is also strictly regulated during development, which ensures naïve cells acquire the appropriate mtDNA copy number as they commit to specific lineages.
Regulation and stability of mtDNA is highly important for oocyte maturation and embryo development Spikings et al., 2007; Cagnone et al., 2016a, b) . Metaphase II (MII) oocytes possess ≥150 000 copies of mtDNA,~30% of the oocyte's total DNA content (Piko and Taylor, 1987) . However, mtDNA deficiency (<100 000 copies) is associated with poor oocyte quality and fertility (May-Panloup et al., 2005; El Shourbagy et al., 2006; Santos et al., 2006) , as these oocytes possess too few copies to support subsequent development since mtDNA replication is not initiated in embryonic cells until post-gastrulation. Indeed, homozygous Polg knockout mice, which possess insufficient copies of mtDNA, die by embryonic Day 7.5 (Hance et al., 2005) . Consequently, oocyte mtDNA copy number is an investment in early development. In addition, it has been proposed that poor quality oocytes harbour higher levels of mtDNA rearrangements (Keefe et al., 1995; Chan et al., 2005) .
Cytoplasmic maturity of oocytes can be assessed using Brilliant Cresyl Blue (BCB) Bhojwani et al., 2007) . BCB distinguishes between oocytes that cease to express glucose-6-phosphate-dehydrogenase and cannot breakdown the dye and stain positively (BCB + ), and oocytes that continue to express the enzyme and breakdown the dye (BCB − ). BCB + oocytes have significantly larger cytoplasmic volumes and more copies of mtDNA, and are more likely to fertilise and develop to the blastocyst stage than BCB − oocytes Cagnone et al., 2016a) . mtDNA-deficient oocytes can be supplemented with autologous populations of mitochondria using mitochondrial intracytoplasmic sperm injection (mICSI) (Cagnone et al., 2016a) . Isolated populations of mitochondria containing mtDNA are derived from oocytes from the same ovary (sister oocytes), and are free of accompanying mRNAs or other cellular factors. They are injected into the oocyte as ICSI is performed. This ensures that mitochondrial genetic integrity is maintained and avoids the use of 'third party' mitochondria, which can be deleterious to development and the offspring's well-being (Barritt et al., 2001; Acton et al., 2007) . In a pig model, mICSI significantly improved blastocyst development rates and induced a mtDNA replication event prior to embryonic genome activation (EGA) (Cagnone et al., 2016a) . Furthermore, blastocysts derived from supplemented BCB − oocytes exhibited gene expression profiles more similar to blastocysts derived from BCB + oocytes than non-supplemented BCB − oocytes (Cagnone et al., 2016a) . Clinically, mICSI has important applications since oocytes obtained from older patients, or those with premature ovarian failure or polycystic ovarian syndrome frequently present with mtDNA deficiency (Chan et al., 2005; May-Panloup et al., 2005; Murakoshi et al., 2013) . This study aimed to determine the molecular differences between mtDNA-normal and mtDNA-deficient MII oocytes and how mitochondrial supplementation enhances the developmental potential of mtDNA-deficient oocytes. This was undertaken using the pig as a model, which closely resembles human physiology and embryo development (Humpherson et al., 2005; Bode et al., 2010) . Firstly, we investigated the levels of mtDNA variants in BCB + and BCB − MII oocytes.
We then determined whether POLG is differentially DNA methylated between the two cohorts. We examined POLG DNA methylation patterns after mtDNA supplementation to determine whether this mediated the increase in mtDNA copy number prior to EGA. Finally, we determined which genes are differentially expressed between BCB + and BCB − MII oocytes by RNA-sequencing. By comparing these outcomes to blastocyst gene expression profiles, we determined which genes were specifically modulated by mtDNA supplementation.
Materials and Methods

Animal ethics statement
Animal ethics committee approval was not required, as ovaries were collected from animals slaughtered for commercial food production.
Experimental procedures were conducted in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes, eighth Edition 2013.
Oocyte collection
Porcine ovaries were transported to the laboratory in sterile phosphatebuffered saline (Sigma, St. Louis, MO, USA) at 35-39°C. Follicles of 3 ± 2 mm in diameter were aspirated using a 18' Gauge needle into a 20 mL syringe containing warm Complete Flush handling medium (ViGRO, Washington, USA). Cumulus-oocyte-complexes (COCs) with at least two layers of cumulus cells were selected for BCB staining and in vitro maturation (IVM).
Brilliant cresyl blue (BCB) staining
COCs were incubated in 12 μM BCB in IVM medium, as described in Cagnone et al. (2016a) .
In vitro maturation of porcine oocytes and MII oocyte collection BCB + and BCB − COCs were washed and cultured separately in Nunc 4-well plates for 44-48 h in pre-equilibrated IVM medium, as previously described (Cagnone et al., 2016a) . Denuded oocytes were rinsed thoroughly 5 times in sterile Dulbecco's phosphate-buffered saline (DPBS; Life Technologies, Carlsbad, CA, USA). Cohorts of single and pooled oocytes were stored in~1 μl DPBS at −80°C.
Mitochondrial isolation
Mitochondrial isolation from oocytes was performed and a concentrated suspension generated and dispensed onto a pre-warmed ICSI plate under oil, as previously described (Cagnone et al., 2016a) .
Mitochondrial supplementation at the time of intracytoplasmic sperm injection (mICSI)
Viable boar sperm (PIC, Grong Grong, Australia) were prepared using the swim-up method and microinjection was performed, both as described in Cagnone et al. (2016a) and Supplementary File 1.
Embryo culture and collection
Embryos were cultured in Porcine Zygotic Media (PZM) at 39°C, 5% CO 2 and 5% O 2 , as previously described (Cagnone et al., 2016a) . At 24 h, uncleaved oocytes, oocytes with 2 polar-bodies, and 2-cell mICSI embryos were collected and stored in~1 μl DPBS at −80°C.
DNA extraction from oocytes
Total DNA was extracted from single and pooled denuded oocytes using the QIAamp DNA Micro kit (Qiagen, West Sussex, UK), according to the manufacturer's instructions.
Whole mitochondrial genome sequencing
Two overlapping products covering the whole mitochondrial genome were generated by long PCR, as described in Tsai et al. (2016) . Primers are listed in Supplementary 
MtDNA sequence variant identification
Variant identification was determined, as similarly described (Tsai et al., 2016) , and in Supplementary File 1.
MtDNA copy number analysis QPCR reactions were performed as previously described (Cagnone et al., 2016a,b) on total DNA extracted from single denuded oocytes or embryos, using primers listed in Supplementary 
Bisulfite conversion and pyrosequencing
Primers covering the target CpG dinucleotides from chr7:59 880 810-59 881 018 (Assembly:Sscrofa10.2/SusScr3) were designed using the PyroMark Assay Design software (v2.0.1, Qiagen). DNA samples (BCB + n = 70; BCB − n = 40; uncleaved oocytes n = 31; oocytes with 2 polarbodies n = 31; 2-cell embryos n = 13) were converted using the Epitect Bisulphite Kit (Qiagen), according to the manufacturer's instructions. The target region was PCR amplified, as similarly described in Lee et al. (2017) , using the PyroMark PCR Kit (Qiagen) with a biotin-labelled reverse primer (Supplementary Table SI) . PCR products were immobilised to Streptavidin Sepharose High Performance beads (GE Healthcare Life Sciences, Uppsala, Sweden) and denatured to single stranded DNA. The pyrosequencing primer (Supplementary Table SI ) was annealed to the template and pyrosequencing was performed on a PyroMark 24 Pyrosequencing system (Qiagen). Results were analysed on the PyroMark Q24 software to determine the % methylation for each CpG site.
RNA extraction
RNA was extracted from oocytes and embryos using the PicoPure ® RNA Isolation Kit (Arcturus, Carlsbad, CA, USA) following the manufacturer's instructions. An in-column DNase I (Qiagen) treatment was added during the wash step to remove genomic DNA. The quality of total RNA was assessed using a 2100 Bioanalyzer system (Agilent Technologies, Santa Clara, CA, USA).
POLG gene expression analysis
RNA from single oocytes (BCB + ; n = 6, BCB − ; n = 6) or single embryos (n = 12; 3 in each cohort) was converted to cDNA using the qScript™ Flex cDNA Kit (Quanta BioSciences, Beverly, MA, USA). A no template control was included. POLG expression was determined by qPCR performed in a Rotergene-3000 qPCR machine (Corbett Research), as described in Cagnone et al. (2016a) . Since ACTIN was stably expressed across all samples, POLG was normalised against ACTIN gene expression for each oocyte or embryo analysed (Supplementary Table SI) .
RNA library preparation and sequencing
Libraries from pooled (n = 5) oocytes (BCB + MII; n = 6 groups; BCB − MII; n = 6 groups) were prepared using the Ovation ® RNA-Seq system V2 (protocol M01206v5) and Ovation ® Ultralow System V2 (protocol M01379v1) (NuGEN Technologies). cDNA was synthesised using the Ribo-SPIA ® technology (NuGEN Technologies), according to the manufacturer's protocol. Each cDNA sample was sonicated using the S220 Focused-ultrasonicator (Covaris) to produce fragments of~320 bp followed by library preparation using the NuGEN workflow stated above.
Qubit Fluorometric quantitation (Invitrogen) and qPCR were used to assess concentration and generate equimolar pools of each barcoded library. RNA sequencing was performed using the 100 bp paired-end sequencing chemistry on the Illumina HiSeq 3000 instrument (protocol 15066493; Illumina) with a PhiX spike-in as a technical control.
Bioinformatics analysis
Quality control was performed for RNA-Seq reads, and adaptors were trimmed using trim_galore v0.4.0 (www.bioinformatics.babraham.ac.uk/ projects; 28 February 2018, date last accessed). Processed reads were mapped to the pig reference genome (GCF_000003025.5_Sscrofa10.2) using Tophat aligner (v2.0.14) (Trapnell et al., 2009) . The reads were mapped to annotated genes in the reference genome and were summarised at the gene level using the featureCounts v1.4.6-p5 software by Liao et al. (2013) . The Remove Unwanted Variation Method (RUV) (Risso et al., 2014) was used to normalise and remove technical artefacts and batch effects. The Generalised Linear Model (GLM) was used for differential comparison between the two cohorts (McCarthy et al., 2012) . Genes with CPM (counts per million) <1 in >8 samples were removed before the remaining CPMs were log transformed to test for differential expression. Differentially expressed genes (DEGs) were identified using R-packages v3.2.0 'edgeR' (v3.10.5) and 'limma ' (v3.24.15) . Differences between groups were presented as LogFC (log-fold-change) and considered significant if the adjusted P-value was <0.05 using the Benjamini-Hochberg multiple testing correction. Gene ontology was determined using the PANTHER classification system (www.pantherdb.org/; 28 February 2018, date last accessed). Network analysis was performed using the Ingenuity Pathway Analysis web-based application (QIAGEN, www.qiagenbioinformatics.com; 28 February 2018, date last accessed, fall 2016 release). RNA sequencing data with a fold difference of >2 and <−2 and significance of P < 0.05 were used to compare with microarray data. RNA sequencing data were deposited into NCBI Gene Expression Omnibus, under the accession number GSE108900.
Statistical analysis
Data analysis was performed using GraphPad Prism v6.0 f (GraphPad Software, Inc., CA, USA). Pyrosequencing data were tested using Tukey's multiple comparisons test. Correlation analysis was performed using the Pearson correlation coefficient. MtDNA copy number analysis was performed using the unpaired two-tailed t-test. POLG expression was tested using one-way ANOVA. Statistical significance is indicated by: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Results
Comparison of mtDNA variants between BCB + and BCB − oocytes during IVM
To determine whether mtDNA variants were indicative of oocyte quality, we compared the whole mitochondrial genome of BCB + (n = 12) and BCB − (n = 12) oocytes during 48 h of IVM using Next Generation sequencing. At the start of IVM (0 h), BCB + and BCB − oocytes had similar frequencies for mtDNA variants, namely 5.45 ± 0.29% and 5.25 ± 0.34% (mean ± SEM), respectively (Fig. 1A) . After 48 h of IVM, immature BCB + and BCB − oocytes had significantly different frequencies for mtDNA variants, i.e. 5.66 ± 0.22% and 6.95 ± , and at the 48 h MII stage (F). *P < 0.05, ***P < 0.001, ****P < 0.0001.
0.61% (P < 0.05), respectively (Fig. 1B) at 0 h (12070 ± 632 cf. 8013 ± 523; P < 0.001; Fig. 1D) ; at 48 h for immature (10 939 ± 432 cf 8445 ± 737; P < 0.05; Fig. 1E ); and for MII oocytes (9937 ± 1175 cf 2691 ± 127; P < 0.0001; Fig. 1F ). Consequently, BCB + oocytes possessed more molecules harbouring mtDNA variants than BCB − oocytes. Furthermore, there were no differences in the number of positions in the mitochondrial genome affected by variants in mature MII oocytes from both cohorts (2.75 ± 0.63 vs. 2.5 ± 0.71) ( Supplementary Fig. S1A, B) . However, variants were differentially regulated in BCB + and BCB − oocytes during maturation.
The relationship between mtDNA copy number and modulation of DNA methylation in POLG for BCB + and BCB − oocytes
To determine whether there were differential patterns of DNA methylation in POLG during IVM, we performed pyrosequencing to interrogate nine CpG dinucleotides within the target CpG island. We determined that the region of interest (Assembly: Sscrofa10.2/susScr3) is homologous to human POLG at exon 2 (Assembly: GRCh38/hg38) (Supplementary Fig. S2 ; Supplementary File 1) with a high degree of similarity between human and pig for the CpG island (Supplementary Fig. S3 (B). **P < 0.01, ***P < 0.001, ****P < 0.0001. Figure 3 Correlation analysis for mtDNA copy number and % DNA methylation in BCB − MII oocytes; and mtDNA-supplemented BCB − -derived uncleaved oocytes, oocytes with 2 polar-bodies and 2-cell embryos at position 1 to 8 (A, B, C, D, E, F, G and H, respectively). Statistical analysis was performed using Pearson correlation coefficient. n = 79; Day 1 immature n = 64; Day 2 immature, n = 80; Day 2 MII, n = 70; Supplementary Fig. S4 ). In contrast, ovarian tissue was highly methylated across all positions. Comparison of the percentage methylation between BCB + and BCB − MII oocytes identified positions 2, 4, 5 and 8 as differentially methylated ( Fig. 2A) .
Modulation of POLG DNA methylation for BCB − oocytes after mtDNA supplementation As mtDNA supplementation leads to a significant increase in mtDNA copy number by the 2-cell stage (Cagnone et al., 2016a) , we supplemented BCB − oocytes with mtDNA at the time of fertilisation and analysed BCB − MII oocytes, and supplemented uncleaved oocytes, oocytes with 2 polar-bodies, and 2-cell embryos to determine if the target region is dynamically modulated. The four differentially methylated CpG dinucleotides (positions 2, 4, 5 and 8) in BCB − MII oocytes were also significantly differentially methylated in the mitochondrial supplemented BCB − oocytes after fertilisation, as were positions 6 and 7 (Fig. 2B) . Pearson correlation coefficient analysis for each CpG dinucleotide ( Fig. 3A-H ) showed that position 6 had the strongest correlation for % methylation and mtDNA copy number (P < 0.02; Fig. 3F ). Composite correlation analysis for positively (positions 2, 5 and 8; Fig. 4A ) and negatively correlated positions (4, 6 and 7; Fig. 4B ) indicated that hypomethylation is associated with higher mtDNA copy number (P < 0.0005; Fig. 4B ).
Expression of POLG transcripts
To determine the effect of POLG methylation on POLG gene expression, we first showed that there were no statistical differences between BCB + and BCB − MII oocytes, although BCB − oocytes showed a trend of expressing more transcripts ( Supplementary Fig. S5A ). Although the levels of POLG transcripts declined from MII to 2-cell embryos ( Supplementary Fig. S5B ), they were still present at the 2-cell stage. The % methylation at position 5 strongly correlated with levels of POLG transcripts (P < 0.03; Supplementary Fig. S6E ). Composite correlation analysis of negatively (positions 2, 5 and 8; Supplementary  Fig. S7A ) and positively (positions 4, 6 and 7; Supplementary  Fig. S7B ) correlated CpG dinucleotides showed that hypomethylation was more strongly associated with higher levels of POLG transcripts (P = 0.0003; Supplementary Fig. S7A ). Howover, composite analysis showed that hypermethylation at positions 4, 6 and 7 was associated with increased POLG expression, albeit to a lesser extent (P = 0.0144). Consequently, POLG transcripts and mtDNA copy number are likely modulated by DNA methylation of POLG. Table SII) . Using the Gene Ontology Consortium database, the top three biological functions for these genes clustered into cell growth and/or maintenance (GO:0009987), metabolic processes resulting in cell growth (GO:0008152), and the establishment and maintenance of cellular component locations (GO:0051179) (Fig. 5A ). Ingenuity Pathway Analysis showed that the DEGs regulated the 'cell-to-cell signalling and interaction, cellular growth and proliferation, and nervous system development and function' (Fig. 5B) ; and 'molecular transport, small molecule biochemistry, and cell-to-cell signalling and interaction' networks (Fig. 5C) . Furthermore, pathway analysis predicted that 'cellular development', 'cellular growth and proliferation', and 'embryonic development' would be affected (Supplementary Table SIII 
mICSI-BCB
− oocytes and ICSI-BCB + oocytes (Cagnone et al., 2016a) .
Using the common DEGs present in the microarray and pooledoocyte RNA-Seq data, we identified six common DEGs as a result of the 'BCB effect' (i.e. BCB + vs. BCB − MII oocytes and BCB + vs. BCB − blastocysts) (Table I) . Common DEGs relevant to mitochondrial function included: Solute carrier family 25 member 11 (SLC25A11), a regulator of α-ketoglutarate transport; TNF receptor associated protein 1 (TRAP1), a regulator of electron transfer through the ETC; and Branched chain amino acid transaminase 2 (BCAT2), which catalyses amino acid metabolism (Table I) . The other genes associated with the 'BCB effect' were COMM domain containing 4 (COMMD4), Autophagy related 9 A (ATG9A), and Family with sequence similarity 163 member A (FAM163A) ( Table I) . We identified seven common DEGs associated with the 'mICSI-effect' (i.e. BCB + vs. BCB − MII oocytes and mICSI-derived BCB − vs. ICSIderived BCB + blastocysts). These included the mitochondrial Malonyl-CoA-acyl carrier protein transacylase (MCAT), a regulator of fatty acid biosynthesis; and transcriptional regulators such as SCY1 like pseudokinase 1 (SCYL1), Zinc finger protein 777 (ZNF777), and PDX1 C-terminal inhibiting factor 1 (PCIF1) ( Table I) . Moreover, the 'mICSI effect' also influenced the expression of DNA repair such Nmethylpurine DNA glycosylase (MPG) and the anti-apoptotic regulator MCL1 (Table I) . Whilst the majority of common DEGs due to the 'BCB effect' were affected, COMM domain containing 4 (COMMD4) remained unchanged (Table I) . However, the expression of BCAT2 was downregulated, which was in agreement with a similar analysis performed on single oocytes and blastocysts (see Supplementary File 1; Fig. S8 ; Table SV ).
Discussion
Identifying good quality oocytes is important for in vitro embryo production (Sirard et al., 2006) . BCB is a non-toxic dye that has been used to assess the cytoplasmic quality of immature oocytes in livestock and humans (Duarte Alcoba et al., 2017). Here, we used BCB to characterise the molecular differences between mtDNA-normal (BCB + ) and mtDNA-deficient (BCB − ) oocytes, and determine how mtDNA supplementation affects preimplantation embryos. We found that mtDNA variants do not contribute to differences in oocyte quality when they develop to MII, as is the case for oocytes from women with ovarian ageing when compared with control oocytes . Additionally, we did not observe the presence of the 4977-bp deletion, which is often associated with poor quality and ageing oocytes (Keefe et al., 1995; Chan et al., 2005) . Furthermore, in a mini-pig model analysed over four generations, high levels of mtDNA variants in oocytes and embryos were stringently suppressed during development and presented at low levels in tissues (Cagnone et al., 2016b) . As mtDNA variants are not indicative of oocyte quality and do not impact on developmental capacity, sister oocytes would be appropriate sources for mitochondrial supplementation. DNA methylation of POLG regulates mtDNA copy number in a cell specific manner and during differentiation in human and mouse (Kelly et al., 2012; Lee et al., 2015) . We found that this intragenic region of porcine POLG was significantly modulated to regulate mtDNA copy number in maturing BCB + oocytes at several CpG dinucleotides and between MII BCB + and BCB − oocytes, which exhibit significant differences in mtDNA copy number. After supplementation of BCB − oocytes, hypomethylation at several CpG dinucleotides corresponded with increased mtDNA copy number. Furthermore, the levels of POLG transcripts and mtDNA copy number were negatively correlated, as observed in mouse embryonic stem cells (Kelly et al., 2012) . This suggests that mtDNA copy number is regulated through a feedback loop between POLG transcripts and the availability of mtDNA, communicated through DNA methylation at POLG CpG sites. Consequently, mtDNA supplementation utilises a small window between fertilisation and EGA, at the 4-cell stage in the pig (Jarrell et al., 1991) , to facilitate a 4.4-fold increase in mtDNA copy number in BCB − -derived 2-cell embryos (Cagnone et al., 2016a) (Dickinson et al., 2013) , tumorigenesis (Dickinson et al., 2013) , fertilisation failure, and embryo arrest. Furthermore, this replication event requires the use of genetically identical mtDNA, such as from sister oocytes. Otherwise, the offspring inherits much of its mtDNA from the donor oocyte, as with cytoplasmic transfer (Brenner et al., 2000) . It is likely that POLG is also differentially expressed in cumulus cells that support oocyte development where embryo quality has been associated with mtDNA copy number in the cumulus cells (DesquiretDumas et al., 2017) . Furthermore, in cumulus cells, mtDNA content, and, the expression of POLG, and two other regulators of mitochondrial biogenesis, OPA1 and TFAM, were linked to oocyte mitochondrial mass (Boucret et al., 2015) with developmental competence in human oocytes also associated with enhanced levels of expression of specific genes in cumulus cells (Cillo et al., 2007) . Therefore, future work could also show how the dynamic nature of POLG expression is regulated in relation to the interaction between the oocyte and its support cells.
By comparing the global gene expression profiles of blastocyst stage embryos and DEGs of BCB + and BCB − oocytes, we identified a number of key factors modulated in mtDNA-deficient oocytes following supplementation including BCAT2. BCAT2 is a key player in amino acid metabolism, which interacts with α-ketoglutarate. BCAT2 knockout mice have improved glucose and insulin tolerance (She et al., 2007) , whereas diabetic mothers have elevated levels of BCAT2 and produce blastocysts with higher BCAT2 levels (Gurke et al., 2015) . Furthermore, our microarray data for mICSI-derived blastocysts showed that the anti-diabetic pathway modulated by Trogilitazone and the resveratrol pathway were modulated by supplementation (Cagnone et al., 2016a) . Therefore, extra copies of mtDNA could promote regulators of mitochondrial biogenesis and cellular metabolism during embryo development to produce metabolites associated with epigenetic modifying enzymes, such as α-ketoglutarate (Matilainen et al., 2017 ) that lead to changes in gene expression profiles (Lee et al., 2017) . Although ICSI is widely used to treat male-factor infertility, it is not effective for female-factor infertility (Tannus et al., 2017) . mICSI could be beneficial clinically by improving the developmental potential of the oocytes of women experiencing repeated developmental failure after assisted reproduction (Fakih et al., 2015) . Similarly, mICSI could be used to rescue poor quality oocytes retrieved from women with premature ovarian failure (May-Panloup et al., 2005) , or following in vitro maturation of oocytes with polycystic ovary syndrome (Harris et al., 2010) .
Taken together, our data indicate that having sufficient copies of mtDNA is important for oocyte quality whilst mtDNA variants do not play a major role in oocyte quality when oocytes mature to MII. We further show POLG methylation is differentially modulated during IVM, and, following mitochondrial supplementation, mediates an increase in mtDNA copy number in mtDNA-deficient oocytes prior to EGA. The extra copies of mtDNA initiate a mtDNA replication event that likely resets the embryonic genome, whereby oocytes predestined to metabolic deficiencies exhibit gene expression profiles at the blastocyst stage more similar to blastocysts from mtDNA-normal blastocysts (see Fig. 6 ). Therefore, sufficient copies of mtDNA are required prior to EGA to promote bi-directional communication between the mitochondrial and nuclear genomes to enhance the expression of embryonic genes.
Supplementary data
Supplementary data are available at Human Reproduction online. Figure 6 The effects of mtDNA supplementation on development. Supplementation of mtDNA-deficient oocytes with~800 copies of mtDNA triggers a mtDNA replication event that resets the embryonic genome prior to EGA and results in modulation of chromosomal gene expression profiles at the blastocyst stage offering greater potential for producing live offspring.
